...
search icon
adpt-img

Adaptive Biotechnologies Corp Share Price

ADPT
NSQ
$18.37
-$0.13
(-0.7%)
1D
Industry: Life Sciences Tools & Services Sector: Health Care

Adaptive Biotechnologies Corp Analyst Forecast

Adaptive Biotechnologies Corp Share Price Chart

Adaptive Biotechnologies Corp Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.82B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.13M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.18
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$6.25 L
$20.76 H
$18.37

About Adaptive Biotechnologies Corp, Common Stock

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. It has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington. more

Industry: Life Sciences Tools & ServicesSector: Health Care

Adaptive Biotechnologies Corp Stock Returns

Time FrameADPTSectorS&P500
1-Week Return-0.27%-1.74%0.38%
1-Month Return12.67%-0.6%0.71%
3-Month Return9.4%7.23%1.76%
6-Month Return77.2%15.31%9.09%
1-Year Return135.37%5.02%14.37%
3-Year Return105.33%17.53%72.79%
5-Year Return-67.08%34.01%84%
10-Year Return-54.09%132.45%258.25%

Adaptive Biotechnologies Corp Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue98.38M154.34M185.31M170.28M178.96M[{"date":"2020-12-31","value":53.09,"profit":true},{"date":"2021-12-31","value":83.29,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.89,"profit":true},{"date":"2024-12-31","value":96.57,"profit":true}]
Cost of Revenue22.53M49.30M57.91M75.55M72.08M[{"date":"2020-12-31","value":29.82,"profit":true},{"date":"2021-12-31","value":65.25,"profit":true},{"date":"2022-12-31","value":76.65,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":95.4,"profit":true}]
Gross Profit75.85M105.04M127.40M94.72M106.88M[{"date":"2020-12-31","value":59.54,"profit":true},{"date":"2021-12-31","value":82.45,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":74.35,"profit":true},{"date":"2024-12-31","value":83.89,"profit":true}]
Gross Margin77.10%68.06%68.75%55.63%59.72%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":88.27,"profit":true},{"date":"2022-12-31","value":89.17,"profit":true},{"date":"2023-12-31","value":72.15,"profit":true},{"date":"2024-12-31","value":77.46,"profit":true}]
Operating Expenses228.67M314.01M327.58M321.76M269.43M[{"date":"2020-12-31","value":69.8,"profit":true},{"date":"2021-12-31","value":95.86,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.22,"profit":true},{"date":"2024-12-31","value":82.25,"profit":true}]
Operating Income(152.82M)(208.97M)(200.19M)(227.03M)(162.55M)[{"date":"2020-12-31","value":-15281700000,"profit":false},{"date":"2021-12-31","value":-20896600000,"profit":false},{"date":"2022-12-31","value":-20018600000,"profit":false},{"date":"2023-12-31","value":-22703500000,"profit":false},{"date":"2024-12-31","value":-16254900000,"profit":false}]
Total Non-Operating Income/Expense13.18M3.34M(364.00K)878.00K5.91M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":25.31,"profit":true},{"date":"2022-12-31","value":-2.76,"profit":false},{"date":"2023-12-31","value":6.66,"profit":true},{"date":"2024-12-31","value":44.83,"profit":true}]
Pre-Tax Income(146.23M)(207.30M)(200.37M)(225.30M)(159.59M)[{"date":"2020-12-31","value":-14622700000,"profit":false},{"date":"2021-12-31","value":-20729800000,"profit":false},{"date":"2022-12-31","value":-20036800000,"profit":false},{"date":"2023-12-31","value":-22530400000,"profit":false},{"date":"2024-12-31","value":-15959500000,"profit":false}]
Income Taxes(6.59M)(1.69M)(57.90M)(54.00K)-[{"date":"2020-12-31","value":-659000000,"profit":false},{"date":"2021-12-31","value":-168700000,"profit":false},{"date":"2022-12-31","value":-5790400000,"profit":false},{"date":"2023-12-31","value":-5400000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(139.64M)(205.61M)(142.46M)(225.25M)-[{"date":"2020-12-31","value":-13963700000,"profit":false},{"date":"2021-12-31","value":-20561100000,"profit":false},{"date":"2022-12-31","value":-14246400000,"profit":false},{"date":"2023-12-31","value":-22525000000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(146.23M)(207.30M)(200.37M)(196.01M)(159.59M)[{"date":"2020-12-31","value":-14622700000,"profit":false},{"date":"2021-12-31","value":-20729800000,"profit":false},{"date":"2022-12-31","value":-20036800000,"profit":false},{"date":"2023-12-31","value":-19600600000,"profit":false},{"date":"2024-12-31","value":-15959500000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(146.23M)(207.28M)(200.19M)(225.25M)(159.49M)[{"date":"2020-12-31","value":-14622700000,"profit":false},{"date":"2021-12-31","value":-20727900000,"profit":false},{"date":"2022-12-31","value":-20019100000,"profit":false},{"date":"2023-12-31","value":-22525000000,"profit":false},{"date":"2024-12-31","value":-15949200000,"profit":false}]
EPS (Diluted)(1.11)(1.47)(1.41)(1.38)(1.09)[{"date":"2020-12-31","value":-111,"profit":false},{"date":"2021-12-31","value":-147,"profit":false},{"date":"2022-12-31","value":-141,"profit":false},{"date":"2023-12-31","value":-138,"profit":false},{"date":"2024-12-31","value":-109,"profit":false}]

Adaptive Biotechnologies Corp Ratios

Adaptive Biotechnologies Corp Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

ADPT
Cash Ratio 2.55
Current Ratio 3.38
Quick Ratio 3.26

Adaptive Biotechnologies Corp Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ADPT
ROA (LTM) -9.32%
ROE (LTM) -37.21%

Adaptive Biotechnologies Corp Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ADPT
Debt Ratio Lower is generally better. Negative is bad. 0.58
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.42

Adaptive Biotechnologies Corp Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ADPT
Trailing PE NM
Forward PE NM
P/S (TTM) 10.98
P/B 13.71
Price/FCF NM
EV/R 10.57
EV/Ebitda NM
PEG NM

FAQs

What is Adaptive Biotechnologies Corp share price today?

Adaptive Biotechnologies Corp (ADPT) share price today is $18.37

Can Indians buy Adaptive Biotechnologies Corp shares?

Yes, Indians can buy shares of Adaptive Biotechnologies Corp (ADPT) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ADPT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Adaptive Biotechnologies Corp be purchased?

Yes, you can purchase fractional shares of Adaptive Biotechnologies Corp (ADPT) via the Vested app. You can start investing in Adaptive Biotechnologies Corp (ADPT) with a minimum investment of $1.

How to invest in Adaptive Biotechnologies Corp shares from India?

You can invest in shares of Adaptive Biotechnologies Corp (ADPT) via Vested in three simple steps:

  • Click on Sign Up or Invest in ADPT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Adaptive Biotechnologies Corp shares
What is Adaptive Biotechnologies Corp 52-week high and low stock price?

The 52-week high price of Adaptive Biotechnologies Corp (ADPT) is $20.76. The 52-week low price of Adaptive Biotechnologies Corp (ADPT) is $6.25.

What is Adaptive Biotechnologies Corp price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Adaptive Biotechnologies Corp (ADPT) is

What is Adaptive Biotechnologies Corp price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Adaptive Biotechnologies Corp (ADPT) is 13.71

What is Adaptive Biotechnologies Corp dividend yield?

The dividend yield of Adaptive Biotechnologies Corp (ADPT) is 0.00%

What is the Market Cap of Adaptive Biotechnologies Corp?

The market capitalization of Adaptive Biotechnologies Corp (ADPT) is $2.82B

What is Adaptive Biotechnologies Corp's stock symbol?

The stock symbol (or ticker) of Adaptive Biotechnologies Corp is ADPT

How Can Investors Use Adaptive Biotechnologies Corp Share Price Data for Long-Term Investment Decisions?

Consider the share price of Adaptive Biotechnologies Corp as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Adaptive Biotechnologies Corp has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Adaptive Biotechnologies Corp shares for Indian investors?

When investing in Adaptive Biotechnologies Corp shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Adaptive Biotechnologies Corp stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Adaptive Biotechnologies Corp share price with other stocks in the same sector?

Rather than merely checking the share price of Adaptive Biotechnologies Corp and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Adaptive Biotechnologies Corp stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top